Effects of drying temperature and storage on parthenolide concentration of feverfew (Tanacetum parthenium L.) leaves

Journal of Nutraceuticals, Functional and Medical Foods

Volumn 4, Issue 1, 2003, Pages 27-37

  Tanko, Hakibu M ^a   Carrier, Danielle J ^a,b   Sokhansanj, Shahab ^a   Crowe, Trever G ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b University of Arkansas   (United States)

Author keywords

Drying; Feverfew; Herb; High Pressure Liquid Chromatography; Migraine; Storage; Tanacetum parthenium

Indexed keywords

TANACETUM PARTHENIUM EXTRACT;

ARTICLE; CONCENTRATION (PARAMETERS); DRUG ISOLATION; DRUG STORAGE; DRUG SYNTHESIS; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIGRAINE; NONHUMAN; PLANT LEAF; POWDER; TANACETUM PARTHENIUM; TEMPERATURE DEPENDENCE;

PARTHENIUM; TANACETUM; TANACETUM PARTHENIUM;

EID: 0037269345     PISSN: 10894179     EISSN: None     Source Type: Journal    
DOI: 10.1300/J133v04n01_04     Document Type: Article

References (16)

1. Awang DVC. Feverfew. Canadian Pharm J, 122:266-270, 1989.
2. Awang DVC. Prescribing therapeutic feverfew (Tanacetum parthenium (L.) SchultzBip., Syn. Chrysanthmum parthenium (L.) Bernh). Int Med, 1:11-131, 1998.
3. De Weerdt CJ, Bootsma HPR and Hendriks H. Herbal medicines in migraine prevention: randomized double-blind placebo-controlled crossover trial of a feverfew preparation. Phytomedicine 3:225-230, 1996.
4. Fitzpatrick KC. Nutraceuticals - a booming industry. In: Herbs 2000 Proceedings International Herb Conference; International Herb Association and Canadian Herb Society: Saskatoon, SK, 2000; pp. 97-103.
5. Groenewegen WA and Heptinstall S. Comparison of the effects of an extract of feverfew and parthenolide on human platelet activity in vitro. J Pharm Pharmacol, 142:533-557, 1990.
6. Hendriks H, Wildeboer YA, Engels G, Bos R and Woerdenbag HJ. The content of parthenolide and its yield per plant during the growth of Tanacetum parthenium. Planta Med, 63:356-359, 1997.
7. Heptinstall S, Awang DVC, Dowson BA, Kindack D, Knight DW and May J. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultzbip.). Estimation of commercial and authenticated feverfew products. J Pharm Pharmacol, 44:391-395, 1992.
8. Heptinstall S, White A, Williamson L and Mitchell JRA. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet 8437:1071-1074, 1985.
9. Johnson ES, Kadam NP, Hylands DM and Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J, 291:569-573, 1985.
10. Kabganian R, Carrier DJ and Sokhansanj S. Drying of Echinacea angustifolia roots. J Herb Spices Med Plants, 10(1):11-18, 2002.
11. Knight WD. Feverfew, chemistry and biological activity. Nat Prod Rep, 12:271-276, 1995.
12. Murphy JJ, Heptinstall S and Mitchell JRA. Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 4, ii:189-192, 1988.
13. Reynolds LB. Effects of drying on chemical and physical characteristics of American ginseng (Panax quinque folius L.). J Herb Spice Med Plant, 6:9-21, 1998.
14. Smith RM and Burford MD. Supercritical fluid extraction and gas chromatographic determination of the sesquiterpene lactone parthenolide in the medicinal herb feverfew (Tanacetum parthenium). J Chromatogr, 627:255-261, 1992.
15. Tanko HM. Physical, chemical, drying and storage characteristics of feverfew (Tanacetum parthenium) leaves. MSc thesis. Department of Agricultural and Bioresource Engineering, University of Saskatchewan, Saskatoon, SK.
16. Zhou JZ, Kou X and Stevenson D. Rapid extraction and high performance liquid chromatographic determination of parthenolide in feverfew (Tanacetum parthenium). J Agric Food Chem, 47:1018-1022, 1999.